(Q42588904)

English

Outcome of allogeneic stem cell transplantation following reduced-intensity conditioninig regimen in patients with idiopathic myelofibrosis: the g.I.T.m.o. Experience

scientific article published on 8 May 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

1 reference

Europe PubMed Central

Outcome of allogeneic stem cell transplantation following reduced-intensity conditioninig regimen in patients with idiopathic myelofibrosis: the g.I.T.m.o. Experience (English)

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

1 reference

based on heuristic

inferred from title

4

object named as

Miriam Isola

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

13

object named as

Renato Fanin

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

author name string

Francesca Patriarca

1

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Andrea Bacigalupo

2

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Alessandra Sperotto

3

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Barbara Bruno

5

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Maria Teresa van Lint

6

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Anna Paola Iori

7

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Paolo Di Bartolomeo

8

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Maurizio Musso

9

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Pietro Pioltelli

10

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Giuseppe Visani

11

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Pasquale Iacopino

12

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Alberto Bosi

14

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

publication date

8 May 2010

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Mediterranean journal of hematology and infectious diseases

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

2

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

2

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

e2010010

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

copyright license

Creative Commons Attribution-NonCommercial 4.0 International

7 May 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033132

28 May 2018

Pros and cons of splenectomy in patients with myelofibrosis undergoing stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033132

28 May 2018

Cyclophosphamide and thiotepa with autologous bone marrow transplantation in patients with solid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033132

28 May 2018

Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033132

16 August 2018

Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033132

16 August 2018

Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033132

16 August 2018

Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033132

16 August 2018

Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033132

16 August 2018

Allogeneic hematopoietic cell transplantation following reduced intensity conditioning for treatment of myelofibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033132

16 August 2018

Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033132

16 August 2018

Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033132

16 August 2018

Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033132

16 August 2018

Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033132

16 August 2018

Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033132

16 August 2018

Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033132

16 August 2018

The role of thiotepa in allogeneic stem cell transplantation in patients with leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21415963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Resea

1 reference

https://pubmed.ncbi.nlm.nih.gov/21415963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21415963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced-intensity conditioning regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/21415963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/21415963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21415963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Splenectomy and hemopoietic stem cell transplantation for myelofibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21415963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21415963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of allogeneic stem cell transplantation in patients with myelofibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21415963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow ino

1 reference

https://pubmed.ncbi.nlm.nih.gov/21415963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic hematopoietic stem cell transplantation for myelofibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21415963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stem cell transplantation for myelofibrosis: a report from two Canadian centers

1 reference

https://pubmed.ncbi.nlm.nih.gov/21415963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)

1 reference

https://pubmed.ncbi.nlm.nih.gov/21415963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4084/MJHID.2010.010

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42588904&oldid=1962224491"